Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. [electronic resource]
Producer: 20011204Description: 143-52 p. digitalISSN:- 1061-4036
- Butadienes -- pharmacology
- Enzyme Activation
- Enzyme Inhibitors -- pharmacology
- Gene Expression Profiling
- Humans
- Immunohistochemistry
- MAP Kinase Signaling System
- Medulloblastoma -- genetics
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Neoplasm Metastasis
- Nitriles -- pharmacology
- Phenotype
- Receptor, Platelet-Derived Growth Factor alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.